Phase III randomized study: Oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia-Reference-Cited by-同舟云学术

Phase III randomized study: Oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia

Published:2009-02 Issue:2 Volume:31 Page:234-243
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Jha Naresh,Seikaly Hadi,Harris Jeffrey,Williams David,Sultanem Khalil,Hier Michael,Ghosh Sunita,Black Martin,Butler James,Sutherland Donna,Kerr Paul,Barnaby Pam

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.20961/fullpdf

Reference41 articles.

1. Cancer statistics 1987;Silverbert;CA,1987

2. Long-term effects of radiotherapy on taste and salivary function in man;Mossman;Int J Rad Oncol Biol Phys,1982

3. Xerostomia: evaluation of a symptom with increasing significance;Fox;J Am Dent Assoc,1985

4. Oral pharyngeal dysphagia: a common sequela of salivary gland dysfunction;Hughes;Dysphagia,1987

5. Nutritional consequences of radiotherapy of head and neck cancer;Chencharick;Cancer,1983

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential effect of acupuncture in xerostomia induced by radiotherapy in head and neck cancer patients: a randomized preliminary study;Revista Internacional de Acupuntura;2022-10

2. Submandibular gland transfer for the prevention of radiation‐induced xerostomia in oropharyngeal cancer: Dosimetric impact in the intensity modulated radiotherapy era;Head & Neck;2022-03-04

3. Radiation-induced swallowing dysfunction in patients with head and neck cancer: A literature review;Journal of the Formosan Medical Association;2022-01

4. Radiotherapy-Induced Digestive Injury: Diagnosis, Treatment and Mechanisms;Frontiers in Oncology;2021-11-05

5. Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline;Journal of Clinical Oncology;2021-09-01